The Swedish biotech startup, Videm, is creating a handheld, low-cost molecular diagnostic device that detects pathogens with high accuracy in less than an hour. Their innovative technology uses nucleic acid amplification and a super sensitive, multiparametric readout. The device is designed for use in care settings or at home, aiming to prevent the spread of infectious diseases and antimicrobial resistance. Founded in 2021, Videm is focused on providing point-of-care diagnosis for infectious diseases.